Sedentary time and markers of chronic low-grade inflammation in a high risk population

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Henson, Joseph ^a,b   Yates, Thomas ^a,b   Edwardson, Charlotte L ^a,b   Khunti, Kamlesh ^a,b   Talbot, Duncan ^c   Gray, Laura J ^d   Leigh, Thomas M ^e   Carter, Patrice ^a,b   Davies, Melanie J ^a,b  

^a National Institute for Health Research ^*  (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNILEVER RESEARCH   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HEMOGLOBIN A1C; INTERLEUKIN 6; LEPTIN; GLYCOSYLATED HEMOGLOBIN;

ACCELEROMETRY; AGED; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; FEMALE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; MALE; PHYSICAL ACTIVITY; SEDENTARY LIFESTYLE; SEDENTARY TIME; UNITED KINGDOM; INFLAMMATION; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADIPONECTIN; ADIPOSITY; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; MOTOR ACTIVITY; RISK FACTORS; SEDENTARY LIFESTYLE;

EID: 84903297018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078350     Document Type: Article

References (45)

1. Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol 8: 457-465.
2. Wang X, Bao W, Liu J, Ouyang YY, Wang D, et al. (2013) Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 36: 166-175.
3. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
4. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, et al. (1997) Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82: 4167-4170.
5. Trayhurn P, Wood IS (2004) Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355.
6. Franks PW, Farooqi IS, Luan J, Wong MY, Halsall I, et al. (2003) Does physical activity energy expenditure explain the between-individual variation in plasma leptin concentrations after adjusting for differences in body composition? J Clin Endocrinol Metab 88: 3258-3263.
7. Ertek S, Cicero A (2012) Impact of physical activity on inflammation: Effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci 8: 794-804.
8. Nader GA, Lundberg IE (2009) Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol 21: 599-603.
9. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, et al. (2011) The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11: 607-615.
10. Kasapis C, Thompson PD (2005) The effects of physical activity on serum Creactive protein and inflammatory markers: A systematic review. J Am Coll Cardiol 45: 1563-1569.
11. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C, et al. (2005) The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: The ATTICA study. Prev Med 40: 432-437.
12. Henson J, Yates T, Biddle SJ, Edwardson CL, Khunti K, et al. (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56: 1012-1020.
13. Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, et al. (2012) Association of sedentary behaviour with metabolic syndrome: A meta-analysis. PLoS One 7: e34916.
14. Thorp AA, Owen N, Neuhaus M, Dunstan DW (2011) Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med 41: 207-215.
15. Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, et al. (2012) Sedentary time in adults and the association with diabetes, cardiovascular disease and death: Systematic review and meta-analysis. Diabetologia 55: 2895-2905.
16. Healy GN, Matthews CE, Dunstan DW, Winkler EA, Owen N (2011) Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J 32: 590-597.
17. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M (2012) Sedentary behavior and adiposity-associated inflammation: The multi-ethnic study of atherosclerosis. Am J Prev Med 42: 8-13.
18. Yates T, Khunti K, Wilmot EG, Brady E, Webb D, et al. (2012) Self-reported sitting time and markers of inflammation, insulin resistance, and adiposity. Am J Prev Med 42: 1-7.
19. Neilson HK, Robson PJ, Friedenreich CM, Csizmadi I (2008) Estimating activity energy expenditure: How valid are physical activity questionnaires? Am J Clin Nutr 87: 279-291.
20. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248.
21. Tataranni PA, Ortega E (2005) A burning question: Does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54: 917-927.
22. Lago R, Gomez R, Lago F, Gomez-Reino J, Gualillo O (2008) Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell Immunol 252: 139-145.
23. Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, et al. (2012) Walking away from type 2 diabetes: Trial protocol of a cluster randomized controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 13: 46.
24. Gray LJ, Davies MJ, Hiles S, Taub NA, Webb DR, et al. (2012) Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55: 959-966.
25. Freedson PS, Melanson E, Sirard J (1998) Calibration of the computer science and applications, inc. accelerometer. Med Sci Sports Exerc 30: 777-781.
26. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, et al. (2008) Breaks in sedentary time: Beneficial associations with metabolic risk. Diabetes Care 31: 661-666.
27. Trost SG, McIver KL, Pate RR (2005) Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc 37: S531-43.
28. The English Indices of Deprivation 2007 Summary. Available: http://webarchive.nationalarchives.gov.uk/20120919132719/http://www.communities.gov.uk/documents/communities/pdf/576659.pdf. Accessed 2013 July 19.
29. World Health Organization 2006: Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Available: http://www.who.int/diabetes/publications/diagnosis-diabetes2006/en/index.html. Accessed 2013 July 19.
30. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, et al. (2009) Correlation of the leptin:Adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52: 2345-2349.
31. Lee CC, Adler AI, Sandhu MS, Sharp SJ, Forouhi NG, et al. (2009) Association of C-reactive protein with type 2 diabetes: Prospective analysis and metaanalysis. Diabetologia 52: 1040-1047.
32. Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, et al. (2005) C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: The strong heart study. Circulation 112: 1289-1295.
33. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369.
34. Yates T, Davies MJ, Gorely T, Talbot D, Bull F, et al. (2010) The effect of increased ambulatory activity on markers of chronic low-grade inflammation: Evidence from the PREPARE programme randomized controlled trial. Diabet Med 27: 1256-1263.
35. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53: 693-700.
36. Kristiansen OP, Mandrup-Poulsen T (2005) Interleukin-6 and diabetes: The good, the bad, or the indifferent? Diabetes 54 Suppl 2: S114-24.
37. Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265: 621-636.
38. Fischer CP, Hiscock NJ, Penkowa M, Basu S, Vessby B, et al. (2004) Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol 558: 633-645.
39. Pedersen M, Steensberg A, Keller C, Osada T, Zacho M, et al. (2004) Does the aging skeletal muscle maintain its endocrine function? Exerc Immunol Rev 10: 42-55.
40. Pedersen BK (2012) Muscular interleukin-6 and its role as an energy sensor. Med Sci Sports Exerc 44: 392-396.
41. Hamilton MT, Hamilton DG, Zderic TW (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56: 2655-2667.
42. Piya MK, McTernan PG, Kumar S (2013) Adipokine inflammation and insulin resistance: The role of glucose, lipids and endotoxin. J Endocrinol 216: T1-T15.
43. Ishii S, Karlamangla AS, Bote M, Irwin MR, Jacobs DR Jr, et al. (2012) Gender, obesity and repeated elevation of C-reactive protein: Data from the CARDIA cohort. PLoS One 7: e36062.
44. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131-2135.
45. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, et al. (2006) Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 20: 498-504.